The Pharmacology Center

Filter Your Results

 

News

 

FDA Approves Amgen’s Repatha for Prevention of Heart Attack and Stroke

December 1, 2017 -- Amgen announced that after priority review of its supplemental Biologics License Application, the US Food and Drug Administration (FDA) approved Repatha (e…

PhaseBio Enters Worldwide License Agreement With MedImmune for a Reversal Agent for Ticagrelor

November 28, 2017 -- PhaseBio Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing therapies for the treatment of orphan diseases, announced that the c…

Study Compares DAPT Durations in STEMI Patients Receiving DES

November 1, 2017 -- Results from the DAPT STEMI were reported at TCT 2017, the 29th annual Transcatheter Cardiovascular Therapeutics scientific symposium being held October 30…

REDUCE Compares 3- and 12-Month DAPT in ACS Patients Treated With the Combo DES

November 1, 2017 -- Results from the prospective, multicenter, randomized investigator-initiated REDUCE trial were reported at TCT 2017, the 29th annual Transcatheter Cardiova…

FDA Approves Expansion of CeloNova's COBRA REDUCE Trial

October 26, 2017 -- CeloNova BioSciences, Inc. announced that the US Food and Drug Administration (FDA) approved expansion of the company's ongoing clinical trial of its C…

Findings Published From CLOSE Trial of PFO Closure After Stroke

September 19, 2017 -- Principal Investigator Jean-Louis Mas, MD, et al published findings from the CLOSE trial in The New England Journal of Medicine (NEJM; 2017;377:1011 -- 1…

ESC Issues 2017 Guidelines on STEMI Management

September 5, 2017 -- The European Society of Cardiology (ESC) recently announced the publication of its 2017 guidelines on the management of acute myocardial infarction in pat…

Study Presented at ESC Suggests No Advantage of Ambulance Versus Hospital Antiplatelet Therapy for STEMI Patients

September 5, 2017 -- The European Society of Cardiology (ESC) announced that a new study presented at the ESC Congress 2017, which was held August 26 -- 30 in Barcelona, Spain…

 

advertisement

2017 Buyer’s Guide

This Buyer’s Guide offers a searchable, comprehensive listing of the FDA-approved interventional devices available in the United States.

 
 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Cardiac Interventions Today

Cardiac Interventions Today (ISSN 2572-5955 print and ISSN 2572-5963 online) is a publication dedicated to providing comprehensive coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions. Cardiac Interventions Today premiered in March 2007 and each edition contains a variety of topics in a flexible format, including articles covering various perspectives on current clinical topics, in-depth interviews with expert physicians, overviews of available technologies, industry news, and insights into the issues affecting today's interventional cardiology practices.